Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China · Delayed Price · Currency is CNY 67.89
+2.89 (4.45%)
At close: Jan 16, 2026
SHA:688192 Market Cap
SHA:688192 has a market cap or net worth of 31.31 billion as of January 16, 2026. Its market cap has increased by 75.96% in one year.
Market Cap
31.31B
Enterprise Value
30.45B
Revenue
607.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
67.89
Market Cap Chart
Since December 10, 2021, SHA:688192's market cap has increased from 16.44B to 31.31B, an increase of 90.45%. That is a compound annual growth rate of 17.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 31.31B | 17.86% |
| Dec 31, 2025 | 26.56B | 54.11% |
| Dec 31, 2024 | 17.24B | -11.74% |
| Dec 29, 2023 | 19.53B | 21.84% |
| Dec 30, 2022 | 16.03B | 7.16% |
| Dec 31, 2021 | 14.96B | -9.01% |
| Dec 10, 2021 | 16.44B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 412.15B |
| WuXi AppTec | 311.06B |
| Shenzhen Mindray Bio-Medical Electronics | 243.32B |
| Sichuan Biokin Pharmaceutical | 130.12B |
| Shanghai United Imaging Healthcare | 112.20B |
| Aier Eye Hospital Group | 105.78B |
| Zhangzhou Pientzehuang Pharmaceutical., | 101.78B |
| Yunnan Baiyao Group Co.,Ltd | 100.28B |